Ben-MenachemEEdrichPVan VleymenBSanderJWSchmidtB. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy. Epilepsy Res2003;53:57–64.
2.
SirsiDSafdiehJE. The safety of levetiracetam. Expert Opin Drug Saf2007;6:241–50.
3.
NaranjoCABustoUSellersEM. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther1981;30:239–45.
4.
MeschedeARungeUSabolekM. Thrombocytopenia during levetiracetam therapy. Epilepsy Res2008;80:91–2.
5.
HartmannHSchumacherUSeeckM. Verschlechterung einer immunthrombopenie unter monotherapie mit levetiracetam. Aktuel Neurol2002;29:467–8.
